References
- Mofijur M, Fattah IMR, Alam MA, et al. Impact of COVID-19 on the social, economic, environmental and energy domains: lessons learnt from a global pandemic. Sustainable Production and Consumption. 2021;26:343–359.
- European Center for Disease Control and Prevention. Interim guidance on the benefits of full vaccination against COVID-19 for transmission and implications for non-pharmaceutical interventions [Internet]. Available from: https://www.ecdc.europa.eu/en/publications-data/interim-guidance-benefits-full-vaccination-against-covid-19-transmission.
- Cierco Seira C. La vacuna-condición o el pasaporte de vacunación y su eventual encaje en un marco general de vacunación recomendada contra la COVID-19. Vacunas. 2021;22(2):82–88.
- Décret n° 2021-955 du 19 juillet 2021 modifiant le décret n° 2021-699 du 1er juin 2021 prescrivant les mesures générales nécessaires à la gestion de la sortie de crise sanitaire. 2021-955 Jul 19, 2021.
- Kaddar M. Economic characteristics of vaccines and immunizations. World Health Organization. [Internet]. [cited 2021 Aug 16]. Available from: www.who.int/influenza_vaccines_plan/resources/session_2_kaddar.pdf.
- EMA. Summary of product characteristics - SPIKEVAX® dispersion for injection [Internet]. 2021 [cited 2021 Aug 25]. Available from: https://www.ema.europa.eu/en/documents/product-information/spikevax-previously-covid-19-vaccine-moderna-epar-product-information_en.pdf.
- EMA. Summary of product characteristics - COMIRNATY® concentrate for dispersion for injection [Internet]. 2021 [cited 2021 Aug 25]. Available from: https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdf.
- ISO. NF EN ISO 7886-1 - Sterile hypodermic syringes for single use — Part 1: Syringes for manual use. 2018.